Product Parameters
| Catalog number | GT-A019 |
|---|---|
| CAS number | 9002-60-2 |
| Sequence | H-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe-OH |
| One-letter sequence | Confirm against the current product specification |
| Molecular formula | C207H308N56O58S1 |
| Molecular weight | Confirm against the current product specification |
| Available purity | Confirm against the current product specification |
| Appearance | Confirm against the current product specification |
| Storage guidance | Confirm against the current product specification |
Supply and Quality Options
Lyophilized powder, bulk material, development sample or custom-filled vial, subject to technical feasibility.
Product specification and batch COA; TDS, SDS and analytical support are confirmed by product and project.
Purity, salt form, fill quantity, packaging, testing and scale can be reviewed for qualified B2B projects.
Packaging and temperature controls are selected against material stability, route, season and destination requirements.
Product Overview
This catalog entry supports qualified B2B sourcing and technical evaluation. Identity data is organized for product matching; final salt form, purity, analytical methods, manufacturing grade, packaging and regulatory documentation are confirmed against the current quotation and quality agreement.
Documentation Available for Review
- Current product specification and identity confirmation
- Batch-specific certificate of analysis where applicable
- Analytical documentation aligned to the agreed quality package
- Storage, packaging and shipment guidance
- GMP, sterile or injectable-development documentation when specifically applicable and contracted
This B2B catalog listing does not represent a marketing authorization, approved indication or finished medicinal product. GMP status, injectable-development suitability, sterility, endotoxin limits, documentation and destination-market regulatory pathway must be confirmed for the exact project and supply agreement.